THE HORMETIC MORPHOGEN THEORY OF CURVATURE AND THE MORPHOGENESIS AND PATHOLOGY OF TUBULAR AND OTHER CURVED STRUCTURES by Fosslien, Egil
Dose-Response: An International Journal
Volume 7 | Issue 4 Article 3
12-2009
THE HORMETIC MORPHOGEN THEORY
OF CURVATURE AND THE
MORPHOGENESIS AND PATHOLOGY OF
TUBULAR AND OTHER CURVED
STRUCTURES
Egil Fosslien
University of Illinois at Chicago
Follow this and additional works at: https://scholarworks.umass.edu/dose_response
This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Fosslien, Egil (2009) "THE HORMETIC MORPHOGEN THEORY OF CURVATURE AND THE MORPHOGENESIS AND
PATHOLOGY OF TUBULAR AND OTHER CURVED STRUCTURES," Dose-Response: An International Journal: Vol. 7 : Iss. 4 ,
Article 3.
Available at: https://scholarworks.umass.edu/dose_response/vol7/iss4/3
307
THE HORMETIC MORPHOGEN THEORY OF CURVATURE
AND THE MORPHOGENESIS AND PATHOLOGY OF TUBULAR AND OTHER
CURVED STRUCTURES
Egil Fosslien, Professor of Pathology (emeritus)  College of Medicine,
University of Illinois at Chicago
 In vitro, morphogens such as transforming growth factor (TGF)-β can up-and down-
regulate cell growth at low and high concentrations respectively, i.e. they behave like
hormetic agents. The hormetic morphogen theory of curvature proposes that in vivo tis-
sue gradients of such morphogens secreted by source cells determine the fate of cells with-
in their gradient fields (field cells) and that morphogen-induced amplitude modulation
of field cell mitochondrial adenosine triphosphate (ATP) generation controls field cell
growth along the morphogen gradients: At the high concentration end of gradients, field
cell ATP generation and field cell growth is reduced. With declining concentrations along
the rest of the gradients field cell ATP and growth is progressively less reduced until an
equidyne point is reached, beyond which ATP generation and growth gradually increases.
Thus, the differential growth rates along the gradients curve the tissue. Apoptosis at very
high morphogen concentrations enables lumen and cavity formation of tubular, spherical,
cystic, domed, and other curved biological structures. The morphogen concentration, the
gradient slope and the hormesis responses of field cells determine the curvature of such
structures during developmental morphogenesis, tissue remodeling and repair of injury.
Aberrant hormetic morphogen signaling is associated with developmental abnormalities,
vascular diseases, and tumor formation.
Key words: Curvature, morphogenesis, hormesis, hormetic morphogen, gradients, development, ather-
osclerosis, cancer
INTRODUCTION
Morphogens such as transforming growth factor beta (TGF-β) in
mammals and auxin in plants can down- and up-regulate basic growth
rates at high and low concentrations respectively, i.e. they can induce
hormetic growth responses. The hormetic morphogen theory of curva-
ture presented in this paper proposes that gradients of hormetic mor-
phogens can 1) modulate production of adenosine triphosphate (ATP)
by cells within their fields (field cells); 2) form curved structures such as
vessel walls by inhibiting cell growth at high and stimulating cell growth
at low morphogen concentrations; 3) induce formation of tubular
lumens and cavities of cyst-like structures via apoptosis and cell disinte-
gration at very high morphogen concentrations; 4) induce hormetic mor-
phogenetic fields that determine the morphology of nodular, tubular,
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and cyst-like and other curved structures in biology. The theory also pro-
poses that the morphogenetic effects can be derailed by inflammatory
mediators. Thus, it suggests a link between chronic inflammation and the
abnormal morphogenesis in atherogenesis and carcinogenesis.
Stated briefly, the theory proposes that development, maintenance,
remodeling, and repair of curved biological structures occur via gene-to-
phenotype cell positional information transfer in the form of morpho-
genetic fields induced by tissue hormetic morphogen concentration-gra-
dients. The morphogens are released by morphogen source cells, and the
morphogen gradients induce tissue curvature by modulating spatial and
temporal growth of field cells via modulation of their ATP generation.
Details of the theory, evidence in its support, and applications to devel-
opmental morphogenesis, developmental malformations and carcino-
genesis are outlined below.
HORMETIC MORPHOGEN GRADIENTS
Morphogens of the TGF-beta (TGF-β) family and the Wingless and
Hedgehog families can form concentration gradients in tissues
(Kerszberg and Wolpert 1998; Mehlen et al. 2005). The TGF beta family
members TGF-betas, bone morphogenetic proteins (BMPs), activin, and
nodals, anti-Müllerian hormone and their receptors and the Wnt super-
families and their receptors play important roles during mammalian
developmental morphogenesis, tissue remodeling, and carcinogenesis
(Jones et al. 1996; McDowell et al. 1997; Barker et al. 2000; Edlund et al.
2005 ; Orvis et al. 2008; Fosslien 2008; Wu and Hill 2009).
To explain the principles of the hormetic morphogen theory of cur-
vature, this paper focuses on the morphogenetic effects of gradients of
hormetic morphogens such as TGF-β and retinoic acid in mammals and
auxin in plants. In vivo, TGF-β is often secreted in an inactive form and
activated by secreted activators, whereas the active form is usually
employed for in vitro studies of the effects of TGF-β.
In vitro, dose-dependent bimodal or biphasic effects of TGF-beta are
characteristic of hormesis; a biological dose-response observed across sci-
entific disciplines such as in toxicology, cancer biology, behavioral phar-
macology, preconditioning, medicine, plant biology and in algae
(Calabrese and Baldwin 1998; Calabrese 2005; Cedergreen et al. 2006;
Calabrese 2008a, 2008b; Mattson 2008; Calabrese and Blain 2009).
Hence, morphogens such as TGF-β, retinoic acid, and auxin in plants that
modulate growth rates in a bimodal or biphasic manner may be charac-
terized as hormetic morphogens.
TGF-β signals through stimulatory and inhibitory pathways. The TGF-
β signaling system thus appears to conform to the definition of a hormet-
ic regulatory system introduced by Calabrese and Baldwin (2001) who
suggested that responses to agonist concentration gradients of hormetic
E. Fosslien
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agents can form generalized hormetic regulatory systems. I believe that
the theory presented in this paper provides plausible mechanisms for a
role for hormetic regulatory systems in the morphogenesis of curved
structures in biology.
CURVATURE
Concepts of the hormetic morphogen theory of curvature grew out
of the interpretation of experimental data obtained by Lin Qiu, a gradu-
ate student in my laboratory, and others (see below). Adapting a Moss
and Benditt (1975) leiomyoma model of proliferation of smooth muscle
cells (SMCs) in atherosclerotic plaques, Qiu (1995) investigated the in
vitro effects of various hormones and growth factors on cell lines derived
from SMCs of human uteri and uterine leiomyomas (fibroids) and found
that transforming growth factor betas (TGF-β1, TGF-β2, TGF-β3) stimulat-
ed and inhibited in vitro growth of uterine SMCs at low and high con-
centrations respectively; the growth modulation was related to log TGF-β
concentration. Other investigators have reported similar dose-dependent
biphasic growth responses to TGF-β by chondrocytes and fibroblasts
(Battegay et al. 1990; McAnulty et al. 1997; Cordeiro et al. 2000)
(Figure 1).
The TGF-β data obtained by Lin Qui showed only moderate (+/- 5-
20%) biphasic growth-modulating effect induced by TGF-β. Nevertheless,
I considered the effect significant for vascular morphogenesis because of
1) the bimodal nature of the effect, 2) the relatively limited thickness of
blood vessel walls, 3) the finding that in vitro, the growth modulation
expressed as a percentage of basic growth rates appeared to be inde-
pendent of the basic growth rate of the different cell lines examined.
In 2002, I proposed that bimodal morphogen gradients could control
the mural curvature and thereby the diameter and shape of tubular, cys-
tic, domed, nodular and other curved structures in biology (Fosslien
2002). I suggested that diffusion/perfusion gradients of TGF-β can
induce tissue curvature along the gradients, forming a concave curvature
as seen from the high concentration end of the gradients. I refer to such
morphogens as concave morphogens and to morphogens that form con-
vex curvature as seen from high concentration ends of morphogen gra-
dients as convex morphogens (Figure 2).
In blood vessel walls, the endothelium may be a source of the hormet-
ic morphogen. Alternatively, in tubular and cystic structures, the luminal
fluid may contain the morphogen. In certain cases, the source of the
hormetic morphogen may not be local. For example, in tubular struc-
tures such as blood vessels, lymphatic vessels and ducts, a morphogen may
be carried from a source location to a different location of gradient for-
mation. In blood vessels, a hormetic morphogen may be released by cells
circulating in the vessels. I shall therefore consider radial gradients such
Hormetic morphogens and curvature
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FIGURE 1. In vitro hormesis: Graphs illustrating hormetic growth responses induced by transform-
ing growth factor (TGF)-β. Low concentrations stimulate and high concentrations inhibit growth.
Left curve illustrates an approximation of data published by McAnulty et al. (1997). Right curve, data
from my laboratory (Qui 1995; Fosslien et al. 1997): Proliferation of smooth muscle cells (SMCs),
average of in vitro triplicate measurements. Controls (C) represents the in vitro growth rates of cor-
responding non-supplemented cells. ΔG%: percent modulation of cell growth compared to controls.
At the equidyne point (EQP), stimulation and inhibition of the growth rates by TGF-β are in balance
and equal to the basic growth rates of control cells. For further details see text. 
FIGURE 2. Curvature formation by hermetic morphogen; single concentration gradient shown on
top left, MGH (hexagon) indicates morphogen gradient head; left middle graph illustrates a theo-
retical hormetic response curve of field cells to the morphogen gradient (compare Figure 1); bot-
tom left graph illustrates a linearized part of the induced growth gradient (ΔG) along the mor-
phogen gradient. Right panel: concave curvature of mural section by radial gradients of the hormet-
ic morphogen (blue arrows) that induce declining inhibition of mural cell growth from morphogen
gradient heads up to the morphogen equidyne line (MEL), beyond which mural cell growth is grad-
ually stimulated. EQC: Morphogen equidyne concentration; EQP: equidyne point of field cell
hormesis curve. At a mural thickness (δ) of 0.5 mm and a 20% morphogen gradient-induced growth
difference (compare Figure 1), the resulting curvature of the wall would result in a theoretical vessel
internal diameter of 5 mm. 
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as those occurring in blood vessels walls as having heads and tails, the
heads being located where the radial mural gradients start (in the fol-
lowing examples the endothelial side) and the tails representing the rest
of the gradient path through the mural tissue (Figure 2).
MODULATION OF ATP PRODUCTION
I propose that radiating diffusion/perfusion gradients of exponen-
tially declining concentration of a hormetic morphogen such as TGF-β
can modulate field cell ATP generation along the gradients in a biphasic,
hormetic concentration-dependent manner: The morphogenetic signal
transmitted by the hormetic morphogen concentration gradients is con-
verted to radiating linear ATP gradients that modulate field cell growth
along the gradients. Along hormetic gradients of declining concentration
at high but declining concentration, field cell ATP generation is progres-
sively reduced less until the morphogen equidyne point (EQP) along the
morphogen gradient is reached, beyond which ATP generation and
growth gradually increases. At the EQP, the inhibitory and stimulatory
forces are in balance, and the ATP production and growth rates of field
cells at this point equal the growth rate of field cells unexposed to the
morphogen. The morphogen concentration at this point is the mor-
phogen equidyne concentration (MEC).
Thus, on each side of the equidyne point, there is a range of linear
amplitude modulation of field cell ATP synthesis (Figure 3A). This dif-
ferential generation of ATP creates radial ATP gradients that modulate
cell proliferation in a corresponding manner with increasing distance
from the gradient head, causing tissues to curve as cell proliferation is
reduced at high concentrations close to the radial gradient heads and
increases along the gradient tails. This is how tissue gradients of a
hormetic morphogen can generate curvature (Figure 3B).
LUMEN FORMATION
The hormetic morphogen theory of curvature proposes that at very
high concentrations, TGF-β and similar hormetic morphogens can form
lumens and cavities via cell disintegration (necrosis and/or apoptosis)
during morphogenesis of tubular biological structures such as blood ves-
sels and cystic structures.
Experiments using retinoic acid support this concept. Retinoic acid is
an essential developmental morphogen (Shroot 1990; Hernandez et al.
2007; Carpenedo et al. 2009) and an upstream regulator of TGF-β expres-
sion (Glick et al. 1989). Chuong et al. (1992) placed beads soaked in dif-
ferent concentrations of retinoic acid ranging from 0.01mg/ml to 1
mg/ml onto explants of avian skin and detected a clear zone of inhibition
of feather buds around the beads starting at 0.05mg/ml. Moreover, the
Hormetic morphogens and curvature
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FIGURE 3A. Tubulogenesis: Role of energetics in curvature formation of a tubular or cystic struc-
ture. Left panels illustrate different single mural gradients of a hormetic morphogen radiating
through mural tissue with thickness δ. The hormetic morphogen gradient (top left) modulates field
cell ATP generation thus forming a mural ATP gradient (middle left) that induces a mural growth
gradient ΔG (bottom left) along the mural morphogen gradient. Right: The radial mural growth gra-
dients curve the mural tissue. Tissue gradients of hormetic morphogens can thus induce concave tis-
sue curvatures as seen from the high concentration end of morphogen gradients. 
FIGURE 3B. Growth gradient (G) regulation of curvature of tissue with thickness δ and at stable field
cell hormesis: The morphogen concentration at the heads of the radial gradients and the slope of
the gradients determine the radius of curvature and thereby the tube or cyst diameter. Top panel,
ΔG0: no growth differential (left), no curvature (right); middle panel: ΔG1, mild growth differential,
mild slope (left), mild curvature (right); bottom panel: ΔG2, large growth differential, steeper slope
(left), more curvature (right). EQDL: equidyne line. 
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investigators reported that the area of inhibition around the beads
appeared linear with retinoic acid concentrations between 0.05mg/ml
and 3mg/ml. At 1mg/ml, buds just outside and adjacent to the clear zone
showed altered morphology and orientation; however, no hormetic
effects on growth were noted.
Upon close examination of the photographic records, it appears
that buds located just outside the clear zones were smaller in size com-
pared to enlarged buds located further away from the pellets, suggest-
ing a hormetic effect of bud size by the diffusing morphogen. To illus-
trate this interpretation, I have outlined such a theoretical effect in
Figure 4 as two concentric zones separated by a morphogen equidyne
line and have additionally provided plots that illustrate the theoretic
hormetic growth modulation along diffusion gradients of retinoic acid
radiating from the pellets.
Segura et al. (2002) found that apoptosis is a requirement for proper
formation of new blood vessels. Using Matrigel assays and human umbil-
ical vein endothelial cells (HUVECs), they showed that inhibition of
apoptosis inhibited vessel formation. Inhibition of apoptosis resulted in
defective vascular structures when vascular endothelial growth factor
(VEGF) and basic fibroblast growth factor (bFGF) were employed to
induce in vitro tubulogenesis in collagen gels. Fierlbeck et al. (2003)
observed that in rats, glomerular capillaries are initially filled with
endothelial cells; based upon in vivo and in vitro studies, the investigators
proposed that central cells are subsequently removed by TGF-β1-depend-
ent apoptosis to create the capillary lumen.
Taken together, these reports indicate that hormetic morphogen-
induced central cell disintegration and/or apoptosis can enable lumen
and cavity formation during hormetic morphogen-induced morphogen-
esis of tubular and cystic structures.
DISCUSSION
Morphogenetic fields
Morphogen gradients are basic forms of morphogenetic fields. The
importance of morphogenetic fields is illustrated by effects of the embry-
onic microenvironment, which can restrain malignant behavior of malig-
nant tumor cells. Malignant tumor cells resemble embryonic cells in their
plasticity, and they can be forced to behave like normal cells when
exposed to proper morphogenetic fields. For example, Illmensee and
Mintz (1976) transplanted teratocarcinoma cells into normal mouse blas-
tocysts and observed that the new environment reversed the cancerous
properties of the transplanted cells. Kulesa et al. (2006) transplanted
human malignant melanoma cells into chick embryonal tissue placing
the transplanted malignant cells next to host pre-migratory neural crest
Hormetic morphogens and curvature
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cells, and observed that the tumor cells developed morphologies that
resembled host neural crest cells. Morphogenetic fields can restrain cell
behavior in plants and fish as well: in tobacco plants, crown gall teratoma
cells participate in the morphogenesis of plants that appear normal, how-
ever, when grown in basic culture medium and thus lacking exposure to
proper morphogenetic fields, the cells regain their malignant phenotype
(Braun and Wood 1976), and invasive type malignant human melanoma
cells transplanted into zebrafish embryos fail to form tumors (Lee et al.
2005).
These experimental findings support the morphogenetic concepts of
the hormetic morphogen theory of curvature because they indicate that
failure of formation and maintenance of morphogenetic fields may play
a causative role in aberrant morphogenesis of developmental abnormali-
ties and diseases such as atherosclerosis and cancer.
E. Fosslien
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FIGURE 4. Evidence-based and theoretical effects of hormetic morphogen radial gradients (blue
arrow) diffusing from central pellet (blue) soaked in the morphogen. A: Very high concentrations of
morphogen causes formation of a pellet-surrounding zone (yellow) of cell disintegration (apoptosis,
necrosis), which is itself surrounded by a coaxial “mural” zone consisting of an inner zone of growth
inhibition (red) and an outer zone of growth stimulation (green) separated by an equidyne line (dot-
ted line). B: Graph illustrates the hormetic morphogen concentration along one radial (blue) gra-
dient d (d=distance) shown in A; small circle illustrates the location of pellet. C. Graph of inhibition
(red) and stimulation (green) of growth along concentrations gradient shown in B.
Apoptosis/necrosis illustrated as negative (yellow arrow) growth (disintegration of cells). D: Graph
of a single mural growth gradient. 
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Energetics and morphogenesis
Child (1915) thought that energy metabolism gradients could
explain embryonal morphogenesis, and that the orderly sequence of
events in time and space during embryogenesis was due to differences in
rate rather that in kind of metabolic reaction. Investigating cancer metab-
olism and viewing cancer morphogenesis as due to dedifferentiation,
Warburg (1956) considered ‘combustion’ - mitochondrial respiration - a
sine qua non for cell differentiation and morphogenesis of higher life
forms.
Along similar lines of thought, in the hormetic morphogen theory of
morphogenesis, I propose that hormetic modulation of growth rates and
thereby curvature along their hormetic morphogen gradients is achieved
by amplitude modulation of mitochondrial generation of ATP, the mito-
chondrial rate-limiting growth regulator in mammals, plants and algae.
The major supply of cellular mitochondrial ATP depends upon the total
number of active mitochondria in a cell, which depends upon the rates
of mitochondrial synthesis and degradation, the fuel supply (food
metabolites), the oxygen available to the mitochondria, and the structure
and function of components of the mitochondrial energy conversion sys-
tem.
In my paper on the role of mitochondrial energetics in cancer mor-
phogenesis (Fosslien 2008), I reviewed experimental evidence which
demonstrates that TGF-β can regulate mitochondrial ATP generation in
several ways. For example, TGF-beta can regulate expression of mito-
chondrial adenine nucleotide transporters (ANT1, ANT2) (Figure 5). In
rodents, TGF-β can regulate ANT1 expression via TGF-β responsive ele-
ments present in the ANT1 promoter, but not in the ANT2 promoter as
it lacks a TGF-β-responsive element (Law et al. 2004). However, TGF-β can
signal via Smad proteins and Sp1; the latter interacts with inhibitory and
stimulatory elements of the ANT2 promoter; TGF-β thus can up-regulate
and down-regulate ANT2 expression in a concentration-dependent man-
ner (Li et al. 1996; Zaid et al. 1999, 2001).
Plant morphogenesis
Experimental evidence indicates that curvature formation in plants
also involves hormetic modulation of mitochondrial energetics. As exam-
ples, the auxin indolacetic acid (IAA) can modulate plant mitochondrial
respiration in a concentration-dependent, biphasic manner, stimulating
respiration at low and inhibiting respiration at high concentration
(Bonner 1933), i.e. IAA can behave like a hormetic agent. IAA can induce
curvature in plants, and the degree of curvature is proportional to the log
of IAA concentration (Bialek et al. 1983). In vitro, at low concentration
(up to about 3 moles/L), IAA stimulates lengths of Avena coleoptiles,
Hormetic morphogens and curvature
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gradually stimulating less up to 10 moles/l, and with further increase in
concentration progressively inhibiting up to 300 moles/L (Foster et al.
1952). Inhibitory IAA concentrations limit coleoptile section elongation.
By comparison, within the stimulatory concentration range, the elonga-
tion rate was steady for up to 10 hours (Kefford and Bonner 1961).
It could be argued that the role of plant mitochondria in plant dif-
ferential growth is quite different from mammalian morphogenesis
because plant mitochondria harbor an alternative oxidase (AOX) system
(Rasmusson et al. 2004). However, plant mitochondria share most basic
features such as cytochrome-dependent respiration with mammalian
mitochondria ( Millerd et al. 1951), and the mechanisms of mitochondr-
ial involvement in auxin-induced curvature formation therefore appear
relevant for elucidating the mechanisms of hormetic morphogen-
induced curvature in biology.
Further credence to these interpretations is given by studies of mor-
phogenesis in the cellular slime mold (slug, Dictyostelium discoideum) and
the amoeba Caenorhabditis elegans. The studies document that morphogen
regulation of mitochondrial energetics is involved in their embryogene-
sis. For example, gradients of differentiation factor-1 (DIF-1) regulate
early embryonic morphogenesis in the slug (Brookman et al. 1987; Kay et
E. Fosslien
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FIGURE 5. Evidence-based examples of regulation of mitochondrial ATP synthesis by charge regu-
lators (DIF-1 and O2) that can limit the amount of fuel-energy conversion to mitochondrial inner
membrane potential (Δψm), or via amplitude modulation of coupling to ATP synthesis by hormetic
morphogens (TGF-β and auxin), or by uncoupling of Δψm energy, either via opening of membrane
pores by apoptotic concentrations of TGF-β or by TGF-β-induced increases in uncoupling protein
(UCP) via cyclooxygenase induction (not shown). TGF-β can modulate ATP synthesis by regulating
the expression of adenine nucleotide transporters (ANT1 and ANT2). Auxin (IAA) can modulate
ADP phosphorylation (For a more complete analysis see Fosslien 2008). 
10
Dose-Response: An International Journal, Vol. 7 [2014], Iss. 4, Art. 3
https://scholarworks.umass.edu/dose_response/vol7/iss4/3
al. 1993) and the amoeba (Ahringer 1995). However, unlike modulation
of mitochondrial energetics by TGF-β, DIF-1 regulates mitochondrial
ATP production via regulation of fuel import into mitochondria (Figure
5).
Shaulsky and Loomis (1995) found that the DIF-1 gene encodes a
vital mitochondrial solute carrier protein and reported that with increas-
ing concentrations above 0.1µM, DIF-1 progressively decreases the mito-
chondrial inner membrane potential (Δψm). They suggested that regula-
tion of mitochondrial energetics by DIF-1 may be a primary means of
establishing and maintaining proportions of cell types in the slug. The
investigators speculated that regulation of energy metabolism may apply
to the morphogenesis in other multicellular developing systems as well.
Oey et al. (2005) identified the amoebal DIF-1 encoded protein as a mito-
chondrial carnitine acylcarnitine transporter. In humans, mutations of
such transporter genes can cause mitochondrial transmembrane trans-
port defects, which are associated with mitochondrial energy deficiencies
that are involved in a number of diseases and if severe, lead to multiple
congenital malformations (Longo et al. 2006; Palmieri 2008).
Malformations
The ability of TGF-β to modulate mitochondrial energetics implies
that aberrant TGF-β signaling can cause secondary mitochondrial dys-
function and failure. Taken together with reports on association of pri-
mary mitochondrial dysfunction due to germline mutations of genes cod-
ing for mitochondrial proteins with development of benign and malig-
nant tumors (Fosslien 2008), these findings indicate that modulation of
mitochondrial energetics plays a essential role of in hormetic mor-
phogen-induced morphogenesis.
Abnormal hormetic morphogen signaling and exogenous substances
that interfere with mitochondrial energetics may lead to abnormal mor-
phogenesis associated with developmental malformation. For example,
use of certain non-steroidal anti-inflammatory drugs (NSAIDs) during
pregnancy increases the risk of developmental malformations, i.e. these
NSAIDs can act as teratogens. Several traditional NSAIDs and some
cyclooxygenase (COX)-2-selective inhibitors can target mitochondria
(Fosslien 1998), and cause mitochondrial dysfunction (Fosslien 2001a).
In mitochondria isolated from rat hearts, aspirin inhibits alpha-ketoglu-
tarate (KGDH) irreversibly, and salicylic acid inhibits the enzyme com-
petitively, reducing electron transfer from the Krebs cycle to the respira-
tory chain and lowering ATP synthesis. In addition, salicylic acid can
cause mitochondrial uncoupling, potentially reducing ATP further
(Nulton-Persson et al. 2004). Indomethacin, diclofenac, and SC-236, a
COX-2-selective inhibitor, can uncouple respiration and decrease ATP
generation of isolated mitochondria and intact cells in vitro (Krause et al.
Hormetic morphogens and curvature
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2003). COX inhibition can also increase levels of arachidonic acid, which
can inhibit OXPHOS and increase generation of reactive oxygen species
(Fosslien 2005). These in vitro NSAID effects may be dose-related, and
since an individual’s over-the-counter NSAID use is often unclear, it is dif-
ficult to estimate the clinical risk of developmental malformation due to
NSAID use.
By comparison, the association is clearer in animal models:
Experimental lack of morphogenetic signaling either by lack of TGF-β3 or
by inhibiting its signal transmission via drug induced mitochondrial dys-
function can cause lack of palate fusion: TGF-β3-/- mouse embryos devel-
op cleft palate and abnormal lungs and the mice die shortly after birth
(Kaartinen 1995; Taya et al. 1999), and some NSAIDs also prevent mouse
palate fusion: Of 5 common NSAIDs (diclofenac, indomethacin, mefe-
namic acid, naproxen, and sulindac) tested for their inhibitory effect on
palate fusion in mice, sulindac was the most teratogenic, whereas
indomethacin was the least teratogenic (Montenegro and Palomino
1990). Studies on isolated rat liver mitochondria and HepG2 cells
revealed that the sulindac metabolite, sulindac sulfide, but not sulindac,
can induce mitochondrial uncoupling, dissipate Δψm, deplete ATP pro-
duction, and cause cell death (Leite et al. 2006).
These examples suggest that use of teratogenic NSAIDs should be
avoided during pregnancy – a period of rapid morphogenesis - because
they may interfere with mitochondrial function and thereby with devel-
opmental hormetic morphogen signaling.
Vascular development
The hormetic morphogen theory of curvature proposes that the cur-
vature and thereby the diameter of blood vessels and other tubular struc-
tures, is mostly determined by the signaling of hormetic morphogen
mural radial gradients and by the hormesis of vessel mural cells. This
interpretation of vascular curvature control may help explain how blood
vessels can adjust their morphology (mural curvature and thereby diam-
eter) to blood flow requirements during intrauterine and post-natal
development, adaptation, and repair.
In vivo, oxygen tension differs between the arterial and venous sides
of the circulation. Reduced oxygen tension can limit the maintenance of
mitochondrial Δψm. Thus, it seems reasonable to expect some differences
in morphogen-induced amplitude modulation of mitochondrial ATP
between the two sides of the vascular system, as it is likely that the horme-
sis of field cells are affected by oxygen tension of their environment.
Thus, hormetic morphogen-induced regulation of vascular diameter may
differ between the arterial and venous side of the circulation.
TGF-β can signal through stimulatory and inhibitory receptor-medi-
ated pathways (Figure 6). Itoh et al. (2009) showed that TGF-β signaling
E. Fosslien
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via both its activin receptor-like kinase (ALK)1 (stimulatory) and ALK5
(inhibitory) pathways are indispensable for in vivo vasculogenesis. Wilcox
and Derynck (1988) detected TGF-β1 mRNA in hematopoietic cells of
capillaries and yolk sac blood islands as early as 9 days p.c., which suggests
that the hematopoietic cells may serve as hormetic morphogen source
cells for TGF-β1 during blood island development and that they are them-
selves resistant to inhibition or apoptosis by the morphogen they secrete,
but that they induce apoptosis of immediately adjacent, non-hematopoi-
etic cells, which then disintegrate and release their plasma, thus forming
the initial blood plasma of blood islands. Once blood circulation has
been established, endothelial cells may also serve as hormetic mor-
phogen source cells. This view is supported by Hannan et al. (1988), who
reported that cultured bovine vascular endothelium cells (aortic and cap-
illary) synthesize and secret the inactive form of TGF-β, and by Carvalho
et al. (2004) who reported that endothelial cells are major contributors of
circulating TGF-β1.
Too much or too little TGF-β signaling is associated with abnormal
yolk sac morphogenesis. Transgenic overexpression of TGF-β1 in vascular
smooth muscle cells (Figure 6, A) causes abnormal and dilated blood
islands to form with the mice dying before E10.5 (Agah et al. 2000). Mice
lacking TGF-β1 (Figure 6, B) or lacking Type II TGF-beta receptors
Hormetic morphogens and curvature
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FIGURE 6. Vascular pathologies: Evidence-based and theoretical diagram illustrating selected aber-
rations of parts of TGF-β1-gradient-induced curvature formation. TGF-β1, secreted by morphogen
source cells and activated by activator (ACTV), form diffusion/perfusion (D/P) gradients that signal
via receptor complexes consisting of TGF-β Type II receptors and endoglin (ENG) and then via
inhibitory (top, ALK5, Smad2/3) and stimulatory (bottom, ALK2 and Smad1/5/8) pathways, reduc-
ing and stimulating mitochondrial synthesis of ATP respectively. Radial hormetic morphogen gradi-
ents up- and down-regulate field cell ATP synthesis. Amplitude modulation of field cell ATP along the
gradients induces differential growth (ΔG) along the tissue gradients (growth gradients), which
induces tissue curvature. HHT: hereditary hemorrhagic teleangiectasia; VMIM: vascular mimicry. For
further explanation see text. 
13
Fosslien: Hormetic morphogens and curvature
Published by ScholarWorks@UMass Amherst, 2014
(Figure 6, C) develop similar defects of yolk sac blood islands (Dickson
1995). Oshima et al. (1996) pointed out that lack of the Type II recep-
tor is more lethal than lack of TGF-β1, and suggested that other TGF-β
isoforms (TGF-β2, TGF-β3) may compensate for loss of TGF-β1 (Figure
6, D). Lack of the TGF-β receptor component endoglin also prevents
proper vascular development: Germline mutation of endoglin (ENG)
(Figure 6, E) or ALK1 (Figure 6, F) genes are associated with lack of
SMC differentiation and hereditary hemorrhagic teleangiectasia
(HHT), and complete lack of endoglin (Figure 6, G) or of the ALK1
gene (ACVR1) is lethal (Figure 6, H). ALK5 expression is required for
mouse yolk sac morphogenesis (Figure 6, J) (Carvalho et al. 2004,
2007). Malignant melanomas can form very narrow vascular channels
referred to as vasculogenic mimicry (VMIM) (Maniotis et al. 1999; Hess
et al. 2007). Their etiology is unknown. However, if perfusion pressure
is very low or lacking due to lack of circulation, their formation could
possibly be caused by very short and steep TGF-β diffusion gradients,
which would induce vascular channels with very high curvature and
very small diameters.
These findings corroborate the model concepts of the hormetic mor-
phogen theory of curvature, i.e. that biphasic effects of hormetic mor-
phogen gradients such as TGF-β serve important functions during yolk
sac vasculogenesis by establishing blood vessel curvature and thereby ves-
sel diameter and help vessels adapt their curvatures to accommodate
developmental and post-natal physiological changes in blood flow
requirements.
Choi and Ballermann (1995) reported that 2ng/ml TGF-β1 can induce
apoptosis and capillary formation of cultured wild-type glomerular capil-
lary endothelial cells; capillary morphogenesis can be inhibited by
neutralizing antibody to TGF-β1 (Figure 6, K) or by transfection of
the endothelial cells with a mutant TGF-β receptor type II gene, which
blocks apoptosis and capillary formation. Moreover, Pollman et al.
(1999) showed that 1ng/ml of TGF-β1 can induce significant apoptosis
in bovine aortic endothelial cells (BAEC) cultured in serum free
media.
Diffuse intimal thickening and atherogenesis
The hormetic morphogen theory of curvature suggests that general
lessening of the inhibitory signaling in the vasculature (Figure 3A, red
lines) would lead to increased field cell proliferation on the concave side
of a concave structure, leading to diffuse intimal thickening (DIT), and
that focal loss of inhibitory signaling could lead to focal intimal thicken-
ing resembling atherosclerotic lesions. It seems likely that atheromas may
also form due to release of hormetic morphogens by platelets depositing
on the intima or by proliferating cells inside the lesions.
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Morphostats
Walshe et al. (2009) suggested that constitutive TGF-β expression may
serve important maintenance functions in the post-natal vasculature.
Thus, TGF-β may to some extent serve as a morphostat, a term coined by
Potter (2001) for agents that exert morphogen-like effects and maintain
fidelity of form in adult tissues. Potter proposed that morphostatic fields
induced by morphostats provide morphostasis, the maintenance of adult
tissue micro-architecture; he suggested that derailed morphostasis, par-
ticularly at the interface between different morphostatic fields, is associ-
ated with metaplasia and cancer (Potter 2007). The Potter morphostat
theory seems to provide valuable insights into morphogenesis. In line
with the hormetic morphogen theory, it supports the idea that aberrant
morphogen signaling is associated with the risk of cancer. However, it fails
to consider both the morphogenetic effects of hormetic morphogens and
the importance of their gradients in curvature control during morpho-
genesis, curvature maintenance, and tissue remodeling and repair.
Cancer
In 2008, I proposed that below a threshold of mitochondrial basic
ATP synthesis, bimodal morphogen signals fail to adequately modulate
mitochondrial ATP synthesis, which leads to loss of morphogen gradient
control of normal tissue curvature that causes formation of abnormal and
neoplastic tissue morphology (Fosslien 2008). This concept is based upon
several reported observations. For example, germline mutations of genes
that encode specific mitochondrial proteins promote formation of
benign and malignant tumors. In response to mitochondrial dysfunction,
cells shift their metabolism from deriving ATP via mitochondrial oxida-
tive phosphorylation to glycolysis together with lactate accumulation.
Otto Warburg, who first observed this effect, considered oxygen metabo-
lism a sine qua non for cell differentiation and development of higher life
forms and viewed the cause of cancer as a lack of mitochondrial ATP. I
suggest that the Warburg effect causes cancer by derailing hormetic mor-
phogen modulation of mitochondrial ATP generation, which disrupts the
flow of genetic information that controls normal curvature formation
and morphogenesis. Accordingly, development of benign and malignant
tumors and invasiveness of cancer cells may be understood as a loss of
morphogen gradient control of tissue curvature. As an example, during
development of cancer from follicular tissue, follicle sizes decrease until
in undifferentiated cancer tissue no curvature is visible. Thus, the
increased cell proliferation of cancer tissues may represent a futile
attempt to restore normal cell differentiation and normal morphogene-
sis when proper mitochondrial function in response to morphogens is
missing: The more hormetic morphogen-induced mitochondrial ATP
Hormetic morphogens and curvature
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modulation is deranged, the more rapid the cell proliferation and the less
differentiated the tumor will appear because feedback of cell differentia-
tion as part of normal morphogenesis is never generated.
It is quite conceivable that in a tumor nodule, oxygen may be a con-
vex morphogen: Along gradients of declining oxygen concentration from
the nodule outside towards the nodule center mitochondrial respiration,
ATP synthesis and cell proliferation would be decreasing, resulting in cur-
vature of the tissue away from the high concentration end of the oxygen
gradients.
Inflammation and morphogen signaling
COX-1, the constitutively expressed isoform of cyclooxygenase, regu-
lates in vitro endothelial cell tubulogenesis (Tsujii et al. 1998). By com-
parison, COX-2 is a multifunctional isoform that in vivo is commonly
expressed at sites of inflammation. Chronic inflammation is involved in
the development of atherosclerosis (Stastny et al. 1986a; 1986b).
Moreover, chronic inflammation is a cancer risk factor, and COX-2 is
over-expressed in many types of human neoplasia, and COX-2 expression
is involved in cancer-induced angiogenesis (Fosslien 2000a, 2000b,
2001b).
Transgenic overexpression of COX-2 reduces TGF-beta type II recep-
tor (RII) expression leading to resistance to inhibitory signaling by TGF-
beta (Hahm et al. 2002). This mechanism may explain why many cancer
cells are resistant to inhibition by TGF-β. In vitro, TGF-β can induce
cyclooxygenase-2 (COX-2) and COX-1, however, the effect is cell specific
(Luo et al. 1998). For example, TGF-β1 induces COX-2 transcription of
cultured pulmonary artery SMCs (Bradbury et al. 2002). Increased
expression of COX-1 or COX-2 affects the synthesis of prostaglandin
(PG). McAnulty et al. (1997) showed that in vitro, PGE2 can participate in
the inhibitory signaling pathway of TGF-β: 40 pg/ml of TGF-β3 or more
inhibited lung fibroblast proliferation. The inhibition could be com-
pletely suppressed by the non-selective cyclooxygenase inhibitor
indomethacin (by comparison, 5 pg/ml (0.2 pM) of TGF-β induced max-
imal stimulation of fibroblast growth). PGE2 can induce expression of
uncoupling protein (UCP), which reduces ATP synthesis by diverting
energy from the mitochondrial inner membrane potential (Δψm) to gen-
eration of heat (Fosslien 2008). Volcik et al. (2003) found that UCP2
mutations can cause neural tube defects, which corroborates other find-
ings that UCP function can affect morphogenesis.
TGF-β signaling via COX-2 expression can also affect the synthesis of
PGJ2 and its derivative, 15-deoxy-Δ12,14-J2 (15d-PGJ2). These
prostaglandins can exhibit biphasic, hormetic effects on cell prolifera-
tion: PGJ2 and 15d-PGJ2 can up- and down-regulate the activity of NADH-
ubiquinone reductase (Complex I) of the mitochondrial respiratory
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chain and induce apoptosis in a concentration-dependent manner (Emi
and Maeyama 2004), i.e. they can behave like a hormetic morphogen. At
very high concentrations, PGJ2 induces mitochondrial formation of radi-
cal oxygen species (ROS), lowers mitochondrial Δψm, and can cause
death of cultured cancer cells even without caspase activation (Pignatelli
et al. 2005).
These findings suggest that chronic inflammation with sustained ele-
vation of COX-2 expression may disrupt hormetic morphogen signaling
and thereby cause aberrant morphogenesis; this mechanism may help
explain why chronic inflammation is a risk factor for atherogenesis and
cancer.
Other theories
Several theories of morphogenesis assume the presence and action of
two opposing agents: an activator and an inhibitor. As examples, Turing
(1990) proposed a ‘reaction-diffusion’ mechanism of pattern formation
involving at least two ‘morphogens’. Schiffmann (1989) noted that cyclic
AMP (cAMP) is the morphogenetic field activator-morphogen and ATP is
the inhibitor; it is assumed that the activator and the inhibitor have dif-
ferent diffusion constants. Cummings (2001, 2006) developed mathe-
matical models of curvature formation for sheets of epithelial cells
induced by two morphogens, each signaling via its own cell surface recep-
tors. He presented an ‘interacting signaling pathway’ mathematical
model of morphogenesis involving two free interacting pairs of extracel-
lular ligands signaling via coupled signaling pathways; activation of any
one of the signaling pathways would suppress the other.
Lewis Wolpert (1969, 1971,1981, 1989, 1994) introduced the concept
of positional information and suggested that it can explain gradient-
induced pattern formation; His ‘French Flag’ model proposes a polar
coordinate system where a diffusible morphogen provides static position-
al information that determines cell fate based upon the coordinates with-
in the gradient field; a cell at a particular coordinate location could inter-
pret the positional information according to its genetic program and
developmental history. He also noted that mechanisms for providing
positional information are similar in Drosophila and vertebrates.
Jaeger and Reinitz (2006) commenting on the French Flag model of
morphogenesis proposed that positional information is not static, but a
dynamic process involving feed-back. Kerszberg and Wolpert (2007) pro-
posed that cell-cell interactions play important roles for cell positional
interpretation.
By comparison, the hormetic morphogen theory of curvature is
based upon in vitro findings that a single morphogen can induce con-
centration-dependent opposite, biphasic, hormetic effects and that, at
very high concentration, such morphogens can induce cell disintegration
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and thus enable the formation of tubular lumens and tissue cavities. It
assumes that in vivo tissue gradients of such a morphogen can control
curvature and cell differentiation along the gradients and thereby con-
trol the morphogenesis of tubular and other curved structure. The theo-
ry considers changes in field cell hormesis during developmental cell dif-
ferentiation to be an important feedback mechanism during hormetic
morphogen curvature formation.
The hormetic morphogen theory of curvature raises several ques-
tions relating to morphogenesis. For example, during atherogenesis,
SMCs from the media migrate into the intima where they proliferate and
contribute to the formation of atheromas. Could this migration and pro-
liferation be caused by a shift in hormetic responses to hormetic mor-
phogen gradients? Do synthetic SMCs exhibit altered hormetic responses
compared to contractile SMCs? Is cell differentiation during morpho-
genesis a major feed-back mechanism during hormetic morphogen cur-
vature formation? Is cancer a disease due to loss of curvature control? In
order to answer these and similar questions it will be necessary to investi-
gate in vitro hormetic responses to hormetic morphogens by different
cell types of the vasculature and differing oxygen concentrations, and, in
the case of cancer, to compare hormetic responses of cancer cells with
those of corresponding cancer-free cells.
Information processing
Benková et al. (2003) noted that during development of a variety of
organs morphogen gradients may be employed in the form of modules;
in plants for example, auxin gradients are involved in the formation of
many types of plant organs. One could also compare information pro-
cessing during morphogenesis to a genetic program that utilizes hormet-
ic morphogen gradient-induced fields like subroutines of a main, overall
genetically-directed whole body morphogenetic developmental program.
Based upon in vitro results (Figure 1) the hormetic morphogen theory of
curvature assumes that within a cell-specific response range, field cells
can perform a log conversion and signal inversion of the hormetic mor-
phogen signal, and that in addition, the signal conversion includes a sig-
nal offset feature, which would explain the morphogen response curve
showing inhibition of growth below the morphogen equidyne concentra-
tion. Such signal conversion modules are common in electronic circuitry,
and the theory assumes that field cells harbor biological circuits that can
perform similar information-decoding functions. One solution has been
offered by Foster et al. (1952) who performed a theoretical analysis of the
kinetics of two-point attachments of auxin to its receptor and concluded
that the enzyme kinetics of such attachments were in complete agree-
ment with experimental results and could fully explain the biphasic
effects of auxin on plant growth.
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Reinhardt et al. (2000) investigated plant patterning and proposed an
auxin-independent apical-basal pattern and a second, auxin-dependent
radial pattern, which may control phyllotaxis, the positioning of leaves on
the stem of plants. Although the investigators did not relate the radial
pattern directly to curvature, there is nevertheless a similarity of thoughts
between their suggestion of two separate patterns in plant morphogene-
sis, a longitudinal and a radial, and my 2002 hypothesis of bimodal mor-
phogen-induced control of curvature of tubular structures and a second
regulator of longitudinal growth, a hypothesis that was developed inde-
pendently, and, as noted above, was based upon laboratory findings of
bimodal effects of TGF-betas on human cells.
The basic theoretical models of curvature formation presented in this
paper assume that mural field cells have the same hormetic response to
the hormetic morphogen. However, in vivo, curved structures may have
layers of different cell types that may exhibit different hormetic respons-
es. Furthermore, it seems likely that in vivo there is an interaction
between cell differentiation, cell type hormesis, and tissue curvature.
Thus, along a gradient of a hormetic morphogen, as cells in the mor-
phogen field differentiate according to differing morphogen gradient
concentrations, curvature responses may change for the different cell
populations that emerge. As example, a multilayered, curved mural struc-
ture such as a blood vessels wall contains morphologically different cell
types, typically separated by elastic laminas, located at interfaces between
the major cell types. The hormetic morphogen theory of curvature pro-
poses that in vivo mural cells may exhibit cell-type specific hormetic
responses, i.e. they may exhibit different hormetic response curves (com-
pare Figure 1). The different hormetic responses would ensures smooth
transitions of curvatures between the different layers of multilayered
curved structures, i.e. an inner layer would exhibit more curvature than
the next outer layer. This concept assumes that cell differentiation and
cellular hormetic responses are interlinked.
It has been suggested that the morphogenesis of complex structures
in distantly related biological systems may involve similar mechanisms
(Wolpert 1989; Meinhardt 1996), but a role for hormesis in mammalian
morphogenesis seems to have evaded major attention. This may possibly
be due to ‘discipline-specific isolation’ (Calabrese 2003), even though
hormesis is a basic phenomenon found not only in mammals but also
across species barriers. The ideas expressed in the theory of curvature
that emerge from a combination of the principles of hormesis and the
observations of biphasic responses to morphogens suggest that concepts
of the hormetic morphogen theory of curvature may apply across species
barriers as well.
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CONCLUSION
In vitro, morphogens such as TGF-β can induce biphasic growth
responses by SMCs and fibroblasts, stimulating growth at low concentra-
tions and inhibiting growth at high concentrations. Similarly, the plant
auxin indolacetic acid (IAA) can induce biphasic growth responses by
coleoptile segments in vitro. These dose responses are characteristic of
hormesis. Therefore, I propose that TGF-β and other morphogens known
to induce biphasic morphogenetic responses may be referred to as
hormetic morphogens. In vitro, TGF-β can modulate mammalian mito-
chondrial ATP synthesis, and IAA can modulate the synthesis of ATP by
plant mitochondria. In both cases, the induced ATP modulations are lin-
early related to the log of the TGF-β and IAA concentrations.
The hormetic morphogen theory of curvature proposes that in vivo,
tissue gradients of exponentially declining concentration of a hormetic
morphogen such as TGF-β in mammals and auxin in plants can modulate
mitochondrial ATP generation by cells in the gradient field (field cells)
in a hormetic, concentration-dependent manner, inhibiting and stimu-
lating ATP generation at high and low morphogen concentrations respec-
tively. The morphogen gradient-induced amplitude modulation of field
cell ATP establishes linear gradients of field cell ATP generation along
the morphogen gradients, which modulates field cell growth and induces
linear growth gradients along the hormetic gradients.
Tissue gradients of hormetic morphogens can thus induce concave
tissue curvature as seen from the high concentration end of the mor-
phogen gradients. Radial growth gradients can induce tubulogenesis
where the morphogen concentration, the slope of the gradients and the
hormetic response of field cells determine the radius of curvature and
thereby the tubular inside diameter. At very high concentrations, hormet-
ic morphogens such as TGF-β and retinoic acid induce cell disintegra-
tion, necrosis, or apoptosis, which enables tubular and cystic lumen for-
mation and tissue cavity formation.
The hormetic morphogen theory views developmental morphogene-
sis and post-natal adaptations of tissue architecture as a dynamic process:
Abnormal hormetic morphogen signaling causes aberrant morphogene-
sis that is associated with human developmental and post-natal patholo-
gies such as malformations, vascular disease, and cancer. The theory
may help explain the role of hormetic morphogens in curvature forma-
tion during vasculogenesis and angiogenesis and elucidate the mecha-
nism involved in vascular abnormalities associated with too much or too
little TGF-β signaling. The biphasic, hormetic effects induced by TGF-β in
vitro, applied to curvature control by theoretical tissue gradients, suggest
that it is the correct balance of hormetic morphogen gradient-induced,
inhibitory and stimulatory signaling that is a sine qua non for proper in
vivo morphogenesis. The central role of mitochondrial energetics in
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hormetic morphogen signaling may explain why primary and secondary
mitochondrial dysfunction is a significant cause of abnormal morpho-
genesis in teratogenesis, vascular diseases, carcinogenesis, and other
human maladies. Furthermore, involvement of COX-2 and prostanoids
in hormetic morphogen signaling links chronic inflammation to athero-
genesis and to carcinogenesis.
Hormesis is a basic phenomenon that occurs in distantly related
organisms. It therefore seems likely that the hormetic morphogen theo-
ry of curvature may apply across species barriers as well and that the mor-
phogenesis of many curved structures in biology may be based on similar,
hormetically regulated morphogenetic mechanisms.
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